DUBLIN Oct. 3 2016 PRNewswire &8212; Allergan plc NYSE AGN today announced that it has entered into a licensing agreement with MedImmune AstraZeneca&8217;s global biologics research and development arm for the global rights to MEDI2070. MEDI2070 is...
↧
Allergan Enters $1.5 Billion Licensing Agreement with AstraZeneca for Inflammatory Disease Candidate
↧